Cigna Group
CIAPI behind this page
CI Q1 2026 request
Playground key active
/api/financials?ticker=CI&year=2026&quarter=1
Pick an endpoint and run the request.Income Statement
| Metric | Q1 2026 | Q1 2025 | YoY |
|---|---|---|---|
| Revenue (Q) | — | — | — |
Show Product Lines breakouts |
|||
| Home delivery and specialty revenues · Evernorth Health Services | 19,788 | 18,937 | +4.5% |
| Network revenues · Evernorth Health Services | 31,080 | 28,212 | +10.2% |
| Other revenues · Evernorth Health Services | 3,426 | 3,077 | +11.3% |
| Product | 54,037 | 48,633 | +11.1% |
| Product · Corporate and Eliminations | -257 | -1,606 | +84.0% |
| Product · Evernorth Health Services | 54,294 | 50,226 | +8.1% |
| Service | 4,443 | 3,895 | +14.1% |
| Service Other | 159 | 162 | -1.9% |
| Service, Fees And Other Revenues [Member] | 4,443 | 3,895 | +14.1% |
| Service, Fees And Other Revenues [Member] · All Other Segments | -3 | 12 | -125.0% |
| Service, Fees And Other Revenues [Member] · Cigna Healthcare | 1,746 | 1,771 | -1.4% |
| Service, Fees And Other Revenues [Member] · Corporate and Eliminations | -1,423 | -1,312 | -8.5% |
| Service, Fees And Other Revenues [Member] · Evernorth Health Services | 4,123 | 3,424 | +20.4% |
| Premiums Earned Net | 9,812 | 12,736 | -23.0% |
Show Product Lines breakouts |
|||
| Employer insured · Cigna Healthcare | 4,996 | 4,688 | +6.6% |
| Individual and Family Plans · Cigna Healthcare | 873 | 859 | +1.6% |
| Other · Cigna Healthcare | 507 | 1,872 | -72.9% |
| Stop loss · Cigna Healthcare | 2,116 | 1,868 | +13.3% |
Show Business Segments breakouts |
|||
| All Other Segments · Operating Segments | 53 | 81 | -34.6% |
| Cigna Healthcare · International Health | 1,113 | 978 | +13.8% |
| Cigna Healthcare · Operating Segments | 9,605 | 12,628 | -23.9% |
| Cigna Healthcare · U.S. Healthcare | 8,492 | 11,650 | -27.1% |
Show Consolidation Items breakouts |
|||
| Corporate and Eliminations | 154 | 27 | +470.4% |
| Net Investment Income | 202 | 238 | -15.1% |
Show Business Segments breakouts |
|||
| All Other Segments · Operating Segments | 70 | 69 | +1.4% |
| Cigna Healthcare · Operating Segments | 103 | 133 | -22.6% |
| Evernorth Health Services · Operating Segments | 25 | 31 | -19.4% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | 4 | 5 | -20.0% |
| Revenue | 68,494 | 65,502 | +4.6% |
Show Business Segments breakouts |
|||
| All Other Segments · Operating Segments | 120 | 175 | -31.4% |
| Cigna Healthcare · Operating Segments | 11,454 | 14,532 | -21.2% |
| Evernorth Health Services · Operating Segments | 58,442 | 53,681 | +8.9% |
Show Consolidation Items breakouts |
|||
| Corporate and Eliminations | -1,522 | -2,886 | +47.3% |
| Cost of Revenue | 54,100 | 48,398 | +11.8% |
Show Business Segments breakouts |
|||
| Evernorth Health Services · Operating Segments | 55,700 | 51,121 | +9.0% |
| Policyholder Benefits And Claims Incurred Net | 7,924 | 10,498 | -24.5% |
Show Business Segments breakouts |
|||
| Cigna Healthcare · Operating Segments | 7,664 | 10,385 | -26.2% |
| Selling, General & Administrative | 3,722 | 4,213 | -11.7% |
| Amortization Of Intangible Assets | 390 | 422 | -7.6% |
Show Business Segments breakouts |
|||
| Cigna Healthcare · Operating Segments | 2 | 7 | -71.4% |
| Evernorth Health Services · Operating Segments | 388 | 415 | -6.5% |
| Benefits Losses And Expenses | 66,136 | 63,531 | +4.1% |
| Operating Income | 2,358 | 1,971 | +19.6% |
| Other Non-Operating Income (Expense) | -357 | -362 | +1.4% |
Show Business Segments breakouts |
|||
| Cigna Healthcare · Operating Segments | 2 | 2 | 0.0% |
| Evernorth Health Services · Operating Segments | -1 | — | — |
| Gain Loss On Sale Of Business | 11 | 41 | -73.2% |
| Net Investment Gain Loss | 258 | -2 | +13000.0% |
| Income Before Taxes | 2,270 | 1,648 | +37.7% |
Show Business Segments breakouts |
|||
| All Other Segments · Operating Segments | 24 | -20 | +220.0% |
| Cigna Healthcare · Operating Segments | 1,481 | 1,364 | +8.6% |
| Evernorth Health Services · Operating Segments | 1,561 | 1,108 | +40.9% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | -796 | -804 | +1.0% |
| Income Tax Expense (Benefit) | 409 | 239 | +71.1% |
| Net Income | 1,861 | 1,409 | +32.1% |
| Net Income Loss Attributable To Noncontrolling Interest | 207 | 86 | +140.7% |
| Net Income | 1,654 | 1,323 | +25.0% |
| EPS (Basic) | 6.3 | 4.88 | +29.1% |
| EPS (Diluted) | 6.26 | 4.85 | +29.1% |
| Comprehensive Income | 862 | 1,074 | -19.7% |
| Wtd Avg Shares (Diluted) | 264,017 | 272,953 | -3.3% |
| Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 (Q) | — | — | — |
Show Business Segments breakouts |
|||
| Cigna Healthcare | 7,664 | 10,384 | -26.2% |
Balance Sheet
| Metric | Q1 2026 | Q1 2025 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 7,040 | 8,334 | -15.5% |
| Short-Term Investments | 812 | 727 | +11.7% |
Show Investment Type breakouts |
|||
| Debt Securities | 453 | 454 | -0.2% |
| Equity Securities | 28 | 11 | +154.5% |
| Mortgages | 52 | 66 | -21.2% |
| Short Term Investments | 279 | 196 | +42.3% |
| Receivables Net Current | 26,607 | — | — |
| Inventory | 5,831 | 5,176 | +12.7% |
| Other Assets Current | 2,742 | 2,389 | +14.8% |
| Total Current Assets | 43,032 | 43,555 | -1.2% |
| Reinsurance Recoverables Non Current | 4,073 | 4,375 | -6.9% |
| Non-Current Assets | |||
| Long Term Investments | 18,902 | 15,350 | +23.1% |
Show Investment Type breakouts |
|||
| Debt Securities | 7,859 | 7,761 | +1.3% |
| Equity Securities | 3,641 | 548 | +564.4% |
| Mortgages | 1,220 | 1,228 | -0.7% |
| Other Long Term Investments | 5,158 | 4,685 | +10.1% |
| Policy Loans | 1,024 | 1,128 | -9.2% |
| Goodwill | 45,534 | 44,372 | +2.6% |
| Other Non-Current Assets | 3,253 | 3,003 | +8.3% |
| Total Assets | 153,266 | 150,658 | +1.7% |
| Other Assets | |||
| Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization | 3,704 | 3,681 | +0.6% |
| Intangible Assets Net Excluding Goodwill | 27,318 | 29,045 | -5.9% |
| Separate Account Asset At Carrying Value | 7,450 | — | — |
| Current Liabilities | |||
| Insurance And Contractholder Liabilities Current | 6,455 | — | — |
| Accounts Payable | 9,879 | 9,136 | +8.1% |
| Debt Current | 1,529 | 3,993 | -61.7% |
| Total Current Liabilities | 52,606 | 55,745 | -5.6% |
| Non-Current Liabilities | |||
| Insurance And Contractholder Liabilities Noncurrent | 9,777 | — | — |
| Deferred Tax Liabilities | 6,851 | 6,879 | -0.4% |
| Other Non-Current Liabilities | 4,769 | 3,579 | +33.2% |
| Total Liabilities | 110,824 | 110,244 | +0.5% |
| Other Liabilities | |||
| Pharmacy And Service Costs Payable | 25,763 | 28,600 | -9.9% |
| Accrued Expenses And Other Liabilities | 8,980 | 8,032 | +11.8% |
| Long Term Debt And Capital Lease Obligations | 29,371 | 26,455 | +11.0% |
| Separate Accounts Liability | 7,450 | 7,277 | +2.4% |
| Stockholders' Equity | |||
| Common Stock | 4 | 4 | 0.0% |
| Additional Paid In Capital Common Stock | 31,914 | 31,443 | +1.5% |
| Accumulated Other Comprehensive Income | -3,598 | -2,590 | -38.9% |
| Retained Earnings | 49,106 | 44,434 | +10.5% |
| Treasury Stock Value | -35,216 | -33,065 | -6.5% |
| Total Stockholders' Equity | 42,210 | 40,226 | +4.9% |
| Minority Interest | 232 | 188 | +23.4% |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 42,442 | 40,414 | +5.0% |
Show Equity Components breakouts |
|||
| Accumulated Defined Benefit Plans Adjustment | -937 | -931 | -0.6% |
| Accumulated Other Comprehensive Income | -3,598 | -2,590 | -38.9% |
| Accumulated Translation Adjustment | -162 | -185 | +12.4% |
| Additional Paid In Capital | 31,914 | 31,443 | +1.5% |
| Common Stock | 4 | 4 | 0.0% |
| Net long-duration insurance and contractholder liabilities measurement adjustments | -2,964 | -2,206 | -34.4% |
| Noncontrolling Interest | 232 | 188 | +23.4% |
| Parent | 42,210 | 40,226 | +4.9% |
| Retained Earnings | 49,106 | 44,434 | +10.5% |
| Securities and derivatives | 465 | 732 | -36.5% |
| Treasury Stock Common | -35,216 | -33,065 | -6.5% |
| Total Liabilities & Equity | 153,266 | 150,658 | +1.7% |
Cash Flow Statement
| Metric | YTD Q1 2026 | YTD Q1 2025 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Depreciation & Amortization | 650 | 674 | -3.6% |
Show Business Segments breakouts |
|||
| All Other Segments · Operating Segments | 2 | 2 | 0.0% |
| Cigna Healthcare · Operating Segments | 83 | 83 | 0.0% |
| Evernorth Health Services · Operating Segments | 560 | 584 | -4.1% |
Show Consolidation Items breakouts |
|||
| Corporate and Eliminations | 5 | 5 | 0.0% |
| Increase Decrease In Deferred Income Taxes | -60 | -216 | +72.2% |
| Increase Decrease In Accounts And Other Receivables | 2,152 | -2,205 | +197.6% |
| Change in Inventory | 1,507 | 1,517 | -0.7% |
| Increase Decrease In Reinsurance Recoverable | 104 | -219 | +147.5% |
| Increase Decrease In Insurance Liabilities | 739 | 1,778 | -58.4% |
| Increase Decrease In Pharmacy And Service Costs Payable | -4,570 | 135 | -3485.2% |
| Increase Decrease In Accounts Payable Accrued And Other Operating Liabilities | -988 | -1,174 | +15.8% |
| Increase Decrease In Other Operating Capital Net | 5 | 260 | -98.1% |
| Net Cash from Operations | 1,131 | 1,920 | -41.1% |
| Investing Activities | |||
| Proceeds From Sale Of Debt And Equity Securities | 54 | 94 | -42.6% |
| Proceeds From Maturities Prepayments And Calls Of Debt And Equity Securities | 185 | 222 | -16.7% |
| Proceeds From Collection Of Loans Receivable | 2 | 85 | -97.6% |
| Proceeds From Sale And Maturity Of Other Investments | 426 | 331 | +28.7% |
| Payments To Acquire Debt And Equity Securities | -362 | -952 | +62.0% |
| Payments To Acquire Mortgage Notes Receivable | -39 | -34 | -14.7% |
| Payments To Acquire Other Investments | -557 | -475 | -17.3% |
| Payments For Proceeds From Property Plant And Equipment | -267 | -327 | +18.3% |
| Proceeds From Divestiture Of Businesses Net Of Cash Divested | 20 | 2,346 | -99.1% |
| Payments To Acquire Equity Method Investments | -94 | -92 | -2.2% |
| Other Investing Activities | -5 | -1 | -400.0% |
| Net Cash from Investing | -637 | 1,197 | -153.2% |
| Financing Activities | |||
| Additions To Contract Holders Funds | 39 | 36 | +8.3% |
| Withdrawal From Contract Holders Funds | -99 | -64 | -54.7% |
| Proceeds From Repayments Of Other Short Term Debt | -13 | -891 | +98.5% |
| Repayments Of Long Term Debt | -550 | -700 | +21.4% |
Show Debt Instrument breakouts |
|||
| 1.250% Notes due March 2026 · Senior Notes | -550 | — | — |
| Proceeds From Issuance Of Common Stock | 57 | 69 | -17.4% |
| Payments Of Dividends Common Stock | -417 | -412 | -1.2% |
| Proceeds From Payments For Other Financing Activities | -158 | -211 | +25.1% |
| Net Cash from Financing | -1,141 | -3,681 | +69.0% |
| Other Cash Flow | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | -9 | 9 | -200.0% |
| Net Change in Cash | -656 | -555 | -18.2% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 7,080 | 8,376 | -15.5% |
Values in millions USD. Source: SEC EDGAR 10-Q filing.